Assessing the Maternal Outcome Monitoring Systems
MOMS
Single Arm Clinical Trial of a Novel Smartphone-based Somatic and Psychological Symptom Monitoring and Decision Support Tool for African American and Spanish Speaking Patients in the Near Postpartum Period
2 other identifiers
interventional
80
1 country
2
Brief Summary
Pregnancy-related death is a growing public health issues, which are of particular concern to minority groups, including African-Americans and Spanish-speaking Latinas. Our proposal aims to improve a patient's ability to detect warning signs of pregnancy related death and seek medical care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 13, 2024
CompletedFirst Posted
Study publicly available on registry
May 16, 2024
CompletedStudy Start
First participant enrolled
December 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
ExpectedJanuary 15, 2026
January 1, 2026
1.4 years
May 13, 2024
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient activation
Change in patient activation measured using the validated Patient Activation Measure (PAM)
Baseline to 6 weeks postpartum
Secondary Outcomes (1)
Knowledge of pregnancy related death warning signs
Baseline to 6 weeks postpartum
Study Arms (1)
MOMS intervention
EXPERIMENTALParticipants in this condition will receive the MOMS symptom monitoring and decision support intervention. This is a single arm trial.
Interventions
The Maternal Outcome Monitoring and Support system is a mobile health application that allows participants to choose symptoms they may be having that are warning signs of pregnancy related death. They then receive decision support about when they should seek medical care (call their provider or go to an emergency room).
Eligibility Criteria
You may qualify if:
- Greater than 28 weeks pregnant
- Receiving healthcare in the United States
- Age 18 years or older
- \[Identify as Black or African American race AND able to speak and read English, AND preferred language of English\] OR \[Identify as Hispanic/Latino Ethnicity AND Spanish able to speak and read Spanish AND preferred language of Spanish\]
- Planned delivery at the following NewYork-Presbyterian hospitals: Children's Hospital of New York, Allen Hospital, Weill Cornell Medical Center, Lower Manhattan Hospital
You may not qualify if:
- Severe cognitive impairment
- Major psychiatric illness
- Concomitant terminal illness that would preclude participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
NewYork-Presbyterian Columbia University Irving Medical Center
New York, New York, 10032, United States
NewYork-Prebyterian/Weill Cornell Medical Center
New York, New York, 10065, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2024
First Posted
May 16, 2024
Study Start
December 11, 2024
Primary Completion
April 30, 2026
Study Completion (Estimated)
January 31, 2027
Last Updated
January 15, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Data will be shared in the aggregate. There is no plan to make IDP available to other researchers.